Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 4 (2007), Issue 7 (July)

1. A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.
   Biochem Biophys Res Commun, 360(1): 149-55. [Abstract] [Full-text]
2. Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.
   J Infect Dis, 196(4): 622-8. [Abstract] [Full-text]
3. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
   J Infect Dis, 196(4): 608-16. [Abstract] [Full-text]
4. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
   J Infect Dis, 196(4): 599-607. [Abstract] [Full-text]
5. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.
   J Infect Dis, 196(4): 550-7. [Abstract] [Full-text]
6. The distinct proteome of placental malaria parasites.
   Mol Biochem Parasitol, 155(1): 57-65. [Abstract] [Full-text]
7. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
   Mol Biochem Parasitol, 155(1): 26-32. [Abstract] [Full-text]
8. Cardiotoxicity of antimalarial drugs.
   Lancet Infect Dis, 7(8): 549-58. [Abstract] [Full-text]
9. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
   Parasite Immunol, 29(8): 387-94. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.